Hill-Rom
Search results
Our mission to save and sustain lives is reflected in our business priorities and our commitment to be an agent of change at a global level. This means doing what is right for our planet, our patients and customers, our teams and our communities.
For nearly a century, we have pioneered significant medical innovations that changed healthcare. From the first commercially produced intravenous solutions to today’s leading acute, nutritional, renal and surgical care innovations, we are committed to providing leading healthcare solutions. Learn More.
Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois. The company primarily focuses on products to treat kidney disease, and other chronic and acute medical conditions. The company had 2017 sales of $10.6 billion, across two businesses: BioScience and Medical Products.
Our global product portfolio enables healthcare professionals to be more efficient and effective in treating patients at the hospital bedside, in the operating theater, in critical care units, at home and in the dialysis clinic.
Baxter International Inc. | 1,030,015 followers on LinkedIn. For nearly a century, we have delivered on our commitment to saving and sustaining the lives of patients, working alongside...
Information regarding Baxter’s recent announcements, upcoming & past events, and other useful resources for investors. Annual Reports & Proxy. Baxter's Annual Chairman Letter, Proxy Statement and Form 10-K filings sorted by year. Financial Schedules. Financial schedules and Non-GAAP reconciliations by quarter. SEC Filings
As an innovative, global healthcare leader, Baxter offers advanced products, technologies and therapies that provide the support people need to lead healthier, longer lives. When you join Baxter, you’ll find purpose and pride as we meet the challenges faced by the patients, clinicians, and customers we serve in this rapidly evolving ...
Find the latest Baxter International Inc. (BAX) stock quote, history, news and other vital information to help you with your stock trading and investing.
Dec 13, 2021 · DEERFIELD, Ill.-- (BUSINESS WIRE)-- Baxter International Inc. (NYSE:BAX), a global medtech leader, announced today it has completed its acquisition of Hillrom. Baxter paid $156.00 in cash for each outstanding share of Hillrom common stock for a purchase price of $10.5 billion (based on Hillrom share counts at closing).
Get the latest Baxter International Inc (BAX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
